M. Saar
Impact in
- Economics and Econometrics top 10%
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
-
- Global Cancer Incidence and Screening
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Ferroptosis and cancer prognosis 1
- Oncology 3
- Cancer Immunotherapy and Biomarkers 3
- Lung Cancer Research Studies 2
- Co-authors
- Nathan I. Cherny (4 shared papers)Alexandru Eniu (3 shared papers)Richard Sullivan (3 shared papers)Julie Torode (2 shared papers)Jana Jaal (4 shared papers)Katrin Sak (1 shared paper)József Lövey (1 shared paper)Michael Shackcloth (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Anticancer Research (1 paper)Pharmaceutics (1 paper)Nursing in Critical Care (1 paper)Lung Cancer (1 paper)
- Partner nations
- EstoniaUnited KingdomRomania
In The Last Decade
M. Saar
11 papers receiving 285 citations
Peers
Comparison fields: 5 of 59
- Economics and Econometrics 79
- Oncology 64
- Pulmonary and Respiratory Medicine 41
- Immunology 27
- Radiology, Nuclear Medicine and Imaging 28
Countries citing papers authored by M. Saar
This map shows the geographic impact of M. Saar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Saar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Saar more than expected).
Fields of papers citing papers by M. Saar
This network shows the impact of papers produced by M. Saar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Saar. The network helps show where M. Saar may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Saar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 127 | |
| 2 | 2017 | 87 | |
| 3 | 2020 | 33 | |
| 4 | 2018 | 15 | |
| 5 | 2025 | 10 | |
| 6 | 2021 | 6 | |
| 7 | 2023 | 5 | |
| 8 | 2021 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2014 | 1 | |
| 11 | 2016 | 1 |
About M. Saar
M. Saar is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Economics and Econometrics, Geriatrics and Gerontology and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 292 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Research Studies (2 papers), Economic and Financial Impacts of Cancer (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Ferroptosis and cancer prognosis (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Pharmaceutical Economics and Policy (1 paper). The work is most often cited by research in Economics and Econometrics (79 citations), Oncology (64 citations), Pulmonary and Respiratory Medicine (41 citations), Immunology (27 citations) and Radiology, Nuclear Medicine and Imaging (28 citations). M. Saar has collaborated with scholars based in Estonia, United Kingdom and Romania. Frequent co-authors include Nathan I. Cherny, Alexandru Eniu, Richard Sullivan, Julie Torode, Jana Jaal, Katrin Sak, József Lövey, Michael Shackcloth, Helmut Prosch and Csaba László Dégi. Their work appears in journals such as Annals of Oncology, Anticancer Research, Pharmaceutics, Nursing in Critical Care and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.